Search Details

Word: patentable (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...created by Ranbaxy, India's largest drugmaker, was bigger than previously thought. That day, Pfizer's stock dipped 3% as investors grappled with the prospect of this unexpected challenge. Ranbaxy, a vigorous exporter to the U.S., claims that its generic version of Lipitor doesn't infringe on Pfizer's patent and is scheduled to argue its case in a Delaware court late next year. And this wasn't the first jolt that the world's biggest pharmaceutical company has suffered from an Indian rival. Last December, a New Jersey court ruled that another Indian company, Dr. Reddy's Laboratories, could...

Author: /time Magazine | Title: Prescription for Profits | 9/15/2003 | See Source »

...panel with a line drawn on it. In 1927, as Philo Farnsworth watched a receiver, his brother-in-law turned a slide in front of a camera. "There you are," said Farnsworth, "electronic television." It was not that simple: Farnsworth spent the next two decades fighting with RCA over patent rights, sinking into depression and drinking. He forbade his kids from watching TV, saying there was nothing worthwhile...

Author: /time Magazine | Title: The Next Big Thing | 9/8/2003 | See Source »

...INDICATORS Drug Deal On the eve of talks in Cancún, the World Trade Organization's executive council approved a deal granting poor countries access to cheaper drugs, after the body's 146 members had agreed to ease patent rules for vital treatments...

Author: /time Magazine | Title: Biz Watch | 8/31/2003 | See Source »

...foreign countries are investing in stem-cell science, the research will ultimately get done. But, says Gearhart, "the U.S. is the 800-pound gorilla when it comes to resources for science. If we continue to limit funding, things will proceed much more slowly." Also, foreign governments and companies can patent their stem-cell lines and charge plenty for licensing them...

Author: /time Magazine | Title: Stem Cells in Limbo | 8/11/2003 | See Source »

...next logical step, says Andrea Bierce, a co-author of the A.T. Kearney study, is jobs that require more complex financial skills such as equity research and analysis or market research for developing new business. Evalueserve, a niche outsourcing company in Delhi, already performs research for patent attorneys and consulting firms in the U.S. In April, J.P. Morgan Chase said it would hire about 40 stock-research analysts in Bombay--about 5% of its total research staff. Novartis employs 40 statisticians in Bombay who process data from the drug company's clinical research...

Author: /time Magazine | Title: Where The Good Jobs Are Going | 8/4/2003 | See Source »

Previous | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | Next